Yes, of course, my guesstimates on lung cancer are for a test - not necessarily a Proteome test.
However Proteome claim that their biomarkers are fully validated and ready for commercialisation. Do you dispute their claim?
Have you read the patents concerned?
Do you agree with the general order of magnitude of the value of the test? Given I have assumed a price of $30 while the competing and less effective spiral Xray costs "hundreds of dollars". So I have been conservative, haven't I?